Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.3880
+0.0520 (15.48%)
At close: May 25, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 22.71 million as of May 26, 2026. Its market cap has increased by 10.30% in one year.
Market Cap
22.71M
Enterprise Value
21.25M
Revenue
33.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 22.71M, a decrease of -35.39%. That is a compound annual growth rate of -2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 25, 2026 | 26.54M | 29.33% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Niutech Group AB | 29.78M |
| Spermosens AB | 28.55M |
| LightAir AB | 25.56M |
| Nattaro Labs AB | 23.82M |
| Transiro Holding AB | 22.08M |
| PolarCool AB | 22.05M |
| Relevance Communication Nordic AB | 21.76M |
| Vaxxa AB | 21.25M |